CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 235 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $518,895 | -87.6% | 19,042 | -89.9% | 0.00% | -87.5% |
Q2 2023 | $4,174,679 | +57.8% | 187,626 | +53.6% | 0.01% | +33.3% |
Q1 2023 | $2,645,249 | +251.3% | 122,126 | +315.8% | 0.01% | +200.0% |
Q3 2022 | $753,000 | -42.4% | 29,372 | -46.6% | 0.00% | -33.3% |
Q2 2022 | $1,307,000 | +496.8% | 54,968 | +452.9% | 0.00% | +200.0% |
Q2 2021 | $219,000 | -80.1% | 9,941 | -78.5% | 0.00% | -80.0% |
Q1 2021 | $1,101,000 | -83.3% | 46,278 | -81.6% | 0.01% | -86.1% |
Q4 2020 | $6,577,000 | -31.3% | 251,400 | -54.3% | 0.04% | -41.0% |
Q3 2020 | $9,578,000 | +49.6% | 550,082 | +2.1% | 0.06% | -4.7% |
Q1 2020 | $6,403,000 | +873.1% | 538,555 | +890.4% | 0.06% | +1180.0% |
Q4 2019 | $658,000 | -84.0% | 54,377 | -81.3% | 0.01% | -84.4% |
Q3 2019 | $4,100,000 | +21.2% | 290,186 | -4.4% | 0.03% | +14.3% |
Q2 2019 | $3,384,000 | -43.0% | 303,504 | -40.0% | 0.03% | 0.0% |
Q1 2019 | $5,940,000 | -22.5% | 505,962 | -11.8% | 0.03% | -64.1% |
Q4 2018 | $7,667,000 | +133.2% | 573,836 | +144.7% | 0.08% | +457.1% |
Q3 2018 | $3,288,000 | – | 234,504 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |